RecruitingNCT04962815
Ceribell Delirium Data Collection Study
Sponsor
Ceribell Inc.
Enrollment
200 participants
Start Date
Nov 10, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study is designed as a prospective, non-randomized, observational clinical study. The study will collect clinical and rrEEG (Ceribell EEG) data when monitoring subjects for delirium subtypes. EEG and clinical data will be collected for the development of future software algorithms to assess the presence and severity of delirium.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Age is 18 years or older
- Admitted to the Intensive Care Unit (ICU)
- Subject must be fluent in the language in which the delirium assessment is performed
Exclusion Criteria1
- \- Any condition that prevents use of the Ceribell EEG system on the subject for the entire anticipated EEG monitoring period. Examples may include: Craniectomy with missing bone flap in an area where Ceribell EEG electrodes are placed. Expected use of continuous clinical EEG for the entire anticipated monitoring period.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEElectroencephalogram (EEG) Test
EEG test and delirium assessments will be performed on subjects experiencing delirium in the ICU.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04962815
Related Trials
Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery
NCT069692871 location
Computer-assisted Cognitive Stimulation Treatment for Delirium
NCT075632441 location
TaVNS for Delirium
NCT072580821 location
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
NCT053730176 locations
Automating Delirium Severity in the ICU
NCT061724911 location